Thompson, R. J. Et Al. 2022. Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial. The Lancet Gastroenterology and Hepatology , vol.7, no.9 , 830-842.

Thompson, R. J., Arnell, H., ARTAN, R., Baumann, U., Calvo, P. L., Czubkowski, P., ... DALGIÇ, B.(2022). Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial. The Lancet Gastroenterology and Hepatology , vol.7, no.9, 830-842.

Thompson, Richard Et Al. "Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial," The Lancet Gastroenterology and Hepatology , vol.7, no.9, 830-842, 2022

Thompson, Richard J. Et Al. "Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial." The Lancet Gastroenterology and Hepatology , vol.7, no.9, pp.830-842, 2022

Thompson, R. J. Et Al. (2022) . "Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial." The Lancet Gastroenterology and Hepatology , vol.7, no.9, pp.830-842.

@article{article, author={Richard J Thompson Et Al. }, title={Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial}, journal={The Lancet Gastroenterology and Hepatology}, year=2022, pages={830-842} }